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Viliuisk encephalomyelitis is an acute, often fatal, me-
ningoencephalitis that tends to develop into a prolonged 
chronically progressive panencephalitis. Clinical, neuro-
pathologic, and epidemiologic data argue for an infectious 
cause, although multiple attempts at pathogen isolation 
have been unsuccessful. To assess mechanisms of disease 
transmission and spread, we studied 6 multiplex families. 
Secondary cases occurred among genetically related and 
unrelated persons in a setting of prolonged intrahousehold 
contact with a patient manifesting the disease. Transmis-
sion to unrelated persons was documented in a densely 
populated region around the city of Yakutsk in which Viliuisk 
encephalomyelitis had not been previously known. Initially 
identiﬁ   ed in a small Yakut-Evenk population on the Viliui 
River of eastern Siberia, the disease subsequently spread 
through human contacts to new geographic areas, thus 
characterizing Viliuisk encephalomyelitis as an emerging 
infectious disease. 
V
iliuisk encephalomyelitis (VE) is clinically and patho-
logically deﬁ  ned as an acute meningoencephalitis that 
progresses to a more prolonged panencephalitic syndrome 
(1–3). In a small number of patients, the initial acute phase 
had gone undetected. Cerebrospinal ﬂ  uid (CSF) pleocytosis 
is present during the acute phase and subsequent progres-
sive stages of illness. Postmortem examination identiﬁ  es 
diffuse inﬁ  ltration of the meninges with mononuclear and 
plasma cells; multiple micronecrotic lesions in the brain 
parenchyma are surrounded by T and B lymphocytes and 
reactive astrocytes (4,5). These disease characteristics sug-
gest that VE is an infectious disease, although the causative 
agent has not been identiﬁ  ed and the mechanisms of dis-
ease transmission and spread remain unknown.
Strong evidence exists that VE is disseminating 
through migration of affected persons from villages along 
the Viliui River in Eastern Siberia, where VE has been en-
demic for at least a century, to densely populated regions 
around the city of Yakutsk (6), located ≈4° (450  km) be-
low the Arctic Circle (7,8). This characterizes VE as an 
emerging infectious disease. From 1950 to 1959, all known 
VE patients were born in villages in the Viliui valley (1), 
whereas in 1970–1979, 32% of VE patients were identi-
ﬁ  ed in previously unaffected regions of Lena and Aldan 
valleys in the vicinity of Yakutsk (7). VE prevalence in 
these newly affected regions remained stable at 35% in the 
decade1980–1989 and has been slowly declining since the 
mid-1990s (9).
A preliminary study of familial aggregation of VE pa-
tients was based on data collected in the 1950s, 1960s, and 
1970s (7,8). Of 194 VE-affected families, 27 had multiple 
VE cases, 2 per family in 24 families and 3 per family in 
3. Secondary cases occurred in 11 full siblings, 3 children 
of the index case-patient, a niece, half-sibling, a cousin, 3 
spouses, and 10 adopted children or other genetically un-
related persons living in the same household (7). The phe-
nomenon of VE clustering in the affected households was 
veriﬁ  ed by statistical analysis. Statistical analyses indicated 
that clustering of >2 cases per family occurred more fre-
quently than should be expected on the basis of family size 
and VE prevalence rates (χ2 test, p = 0.00036) (7,8).
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We sought to document and better characterize the 
phenomenon of VE clustering in the affected households. 
We conducted a detailed study of 5 families living in vil-
lages along the Viliui River and of 1 family in the region 
surrounding the city of Yakutsk, to which the disease has 
recently spread (Figure).
Patients and Methods
VE patients were identiﬁ  ed by physicians from neurol-
ogy services established in the 1950s in Viliuisk (1,3) and 
Yakutsk (6). Early detection and frequent follow-up of VE 
patients were accomplished by village-to-village searches 
and periodic hospitalizations. VE diagnoses were made ac-
cording to established clinical (2,3) and pathologic (4) cri-
teria; standardized neurologic assessment was performed 
on all patients, and neuropathologic examination was per-
formed by 3 independent groups (4,5,10). In the 50-year pe-
riod between 1950 and 2000, 301 patients were identiﬁ  ed. 
Families with 2 or more patients were repeatedly studied in 
the villages by visiting epidemiologist/neurologist teams, 
which collected epidemiologic data and reviewed medical 
histories. Six well-characterized VE-affected families with 
2 or 3 patients were included in the current study; neuro-
pathologic examination was performed on 1 patient from 
each family.
Studies were conducted under clinical protocols ap-
proved by the Institutional Review Boards of the Institute 
of Health, Sakha (Yakut) Republic, and the US National In-
stitutes of Health. The protocol was subsequently reviewed 
and approved by the Ofﬁ  ce of Protection from Research 
Risks, US Department of Health and Human Services 
(OPRR-S-16078–01). Informed consent was obtained for 
each element of this study.
Results
Five families originated from settlements in a high-
incidence middle Viliui region with a rural population of 
10,000, composed of remnants of the indigenous Tungus 
(Evenk) tribes that have been largely assimilated by the 
dominant Yakut (Sakha) people. Families 1, 3, and 4 were 
identiﬁ  ed in villages around Lake Mastakh, the peak VE-
endemic area; family 2 was from a village near the town 
of Viliuisk; family 5 was identiﬁ  ed in a settlement 100 km 
down the Viliui River; and family 6 was studied near the 
capital city of Yakutsk, ≈400 km southeast of Lake Mas-
takh (Figure). The population in this central region is ethnic 
Yakut (Sakha).
Family 1 
Family 1 consisted of 2 parents and 5 siblings (3 daugh-
ters and 2 sons).VE developed in each daughter; no other 
VE patients were identiﬁ  ed in the extended pedigree of this 
family. In the index case-patient (patient 1-1, Table 1), the 
second-born daughter, high fever, severe headache, my-
algia, chills, and double vision developed when she was 
16 years of age in 1954. She was admitted to the hospital 
in a coma and remained drowsy and mentally and physi-
cally slow for 6 weeks. Six months later, she had a relapse 
of a febrile illness with persistent neck stiffness, Kernig 
sign, and repetitive generalized seizures. After the acute 
phenomena subsided, she showed evident cognitive im-
pairment, upper motor neuron pattern of weakness in limb 
muscles, hyperactive deep tendon reﬂ  exes, bilateral Babin-
ski sign, dysarthric speech, and spastic gait. Ten months 
after disease onset, she exhibited dementia dysarthria and 
spastic quadriparesis. The disease progressed relentlessly, 
and the patient died 18 months after the onset of symptoms. 
Cell count and protein concentration level were consistent-
ly abnormal during the entire course of illness (the results 
of CSF testing and neuropathologic ﬁ  ndings are listed in 
Table 2).
The eldest sister (patient 1-2) became acutely ill at 38 
years of age, 15 years after the death of patient 1-1. She 
exhibited high fever, chills, headache, myalgia, nausea, and 
frequent vomiting and was comatose when admitted to the 
hospital; examination ﬁ  ndings included dysphagia, neck 
stiffness, and Kernig sign. The patient’s condition rapidly 
deteriorated, and she died on day 75 of illness. On postmor-
tem examination, the meninges were thickened and inﬁ  l-
trated with mononuclear, plasma, and polymorphonuclear 
cells. Inﬂ  ammatory changes were especially pronounced in 
the meninges overlying the affected cortical areas. In the 
brain, multiple widespread micronecrotic foci surrounded 
by inﬂ  ammatory inﬁ  ltrates were observed throughout the 
cerebral cortex, basal ganglia, cerebellum, and brain stem. 
The inﬁ  ltrates were composed of lymphocytes (predomi-
nantly T-cells with occasional B-cells), microglial cells, 
macrophages, and reactive astrocytes. Perivascular cuffs 
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Figure. Location of families with Viliuisk encephalomyelitis 
characterized in this report. Arrow indicates the general direction 
of Viliuisk encephalomyelitis dispersion from traditional disease-
endemic areas on the Viliui River to densely populated regions of 
the Sakha (Yakut) Republic around the capital city of Yakutsk.Viliuisk Encephalomyelitis
consisting of mononuclear cells were widespread in the 
affected areas. Diffuse neuronal loss was observed within 
and outside the affected areas. Mild ﬁ  brillary gliosis in its 
early stages was present in the affected areas of pontine 
nuclei and inferior olives (5).
The youngest sister (patient 1-3) had a 2-week febrile 
illness with headache, chills, and insomnia at the age of 22, 
11 years after the death of patient 1-1. Subsequently, cog-
nitive decline, muscle stiffness, dysarthria, and spastic gait 
developed. Disease progression slowed 10 years after the 
onset, and she is still alive in her 39th year of illness.
Family 2
In family 2, which consisted of parents and 6 siblings 
(3 sisters and 3 brothers), an acute febrile illness developed 
in the second-born sister (patient 2-1) when she was 16 
years of age. She recovered, but 3 months after the onset 
became slow mentally and clumsy physically, with spastic 
gait and frequent falls. Seven months after the disease onset, 
she was admitted to the hospital with recurrent generalized 
tonic-clonic seizures, cognitive decline, dysarthria, brisk 
tendon reﬂ  exes throughout, ﬂ  exor and extensor pathologic 
reﬂ  exes, increased muscle tone, and spastic gait. The dis-
ease relentlessly progressed; 28 months after the disease 
onset, she was obese, demented, dysarthric, with muscle 
weakness and spastic gait. She died 48 months after symp-
tom onset. CSF tests suggested inﬂ  ammatory brain disease 
(Table 2).
In the oldest sister (patient 2-2) a sudden febrile ill-
ness developed when she was 44 years of age, 16 years 
after her younger sister’s death. She sought treatment for 
severe headache, confusion, nausea, and vomiting and had 
meningeal signs on examination. During hospitalization, 
she remained febrile, and hyperactive tendon reﬂ  exes de-
veloped along with ankle clonus, bilateral Babinski sign, 
progressive dysphagia, and respiratory failure. The patient 
died 72 days after disease onset. Results of postmortem 
examination were consistent with the diagnosis of acute 
meningoencephalitic form of VE (Table 2). No other VE 
patients are known among the immediate or distant family 
members.
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Table 1. Clinical features of Viliuisk encephalomyelitis in affected members of 6 families* 
Family 1  Family 2  Family 3  Family 4  Family 5  Family 6 
Feature 1-1 1-2 1-3 2-1 2-2 3-1 3-2 4-1 4-2 4-3 5-1 5-2 6-1 6-2 6-3
S e x    FFFFFFM MFFFFMFF
Age at onset, y  16 38 26 16 44 31 21 51 47 36 20 34 46 37 53
Febrile stage of illness 
 Duration,  wk  7 11 2 2 10 ND 2 ND ND 4 ND 1 ND 6 26
 Maximum  temperature, 
oC 40.5 39 38 37.9 39.8 39.0 39.0 ND 38.5 38.8
  Reduced level of  
 consciousness 
++ +++ + +++ + ++ + +++
 Generalized  seizures  ++ + +
  Neck rigidity and Kernig sign  + ++ + ++ + + +
 Nausea,  vomiting  + ++ + ++ ++ +
  Upper motor neuron pattern  
  of muscle weakness 
++ ++
  Relapse of febrile illness   + + + +
 O u t c o m e     adaadaaaaaaaaad
Advanced disease 
 Cognitive  decline  ++ + ++ m.i. ++ ++ ++ ++ ++ ++ + ++
 Apathy  + + ++ + + + +
 Dysarthria  +++ ++ ++ ++ + ++ + ++ + +
 Dysphagia  + + + +
  Brisk deep tendon reflexes  ++ ++ ++ ++ ++ ++ + ++ + ++ + ++
 Spastic  quadri/paraparesis  +++ + ++ + ++ + ++ +++ – + + –
  Increased muscle tone  + + + + ++ + + ++ – + +
 Babinski  sign  + + + + + + + +
  Spastic gait   +++ ++ ++ + +++ + + + + + + +
 Falls  + ++ + + +
 Sphincter  dysfunction  + ++ ++ +
 Extrapyramidal  rigidity  + + ++ + ++ ++ + + + +
 Obesity  + + + +
 Cachexia  + + ++ +








17 y  24
mo
9 y  6 y  11
mo
11 y  23
mo




*ND, not documented; m.i., memory impairment; +, mild; ++, moderate; +++, strong; –, not expressed; d, died within acute phase; a, advanced disease 
developed; A, alive. RESEARCH
Family 3
Family 3 comprised an affected mother (patient 3-1) 
and her 3 sons; VE developed in the mother in 1953 and 
in her oldest son (patient 3-2) in 1973. Patient 3-1 had an 
insidious onset of muscle stiffness, gait disturbance, dysar-
thria, and memory impairment at the age of 31. On examina-
tion, she had severe dysarthria, moderate muscle weakness 
in the lower limbs, brisk tendon reﬂ  exes, ﬂ  exor pathologic 
signs, spastic gait, and bilateral mild muscle atrophy of the 
hand and forearm muscles. The disease progressed slowly, 
and the patient died 17 years after onset.
In patient 3-2, a 2-week febrile illness developed when 
he was 21 years of age, with severe headache and dizzi-
ness, 2 years after his mother’s death. He recovered but was 
unable to do any work on his family’s farm. The follow-
ing year, rapidly progressive dementia, dysarthria, muscle 
stiffness, and spasticity developed. On examination, he had 
brisk tendon reﬂ  exes with ankle clonus, spastic quadripa-
resis, and decreased proprioceptive sensation in the lower 
limbs with preserved vibration sense. Later he had bulbar 
symptoms and atrophy of small muscles of the hands and 
feet and died in respiratory distress 24 months after disease 
onset. A cranial computed tomographic scan showed corti-
cal atrophy and diffuse leptomeningeal enhancement over 
the parietal and occipital lobes.
Study of the neuropathologic features of patient 3-2 
showed thickened and cloudy meninges and microscopi-
cally diffuse inﬁ  ltration with mononuclear, plasma, and 
polymorphonuclear cells. Organized necrotic foci with 
central lysis of tissue and adjacent reactive gliosis were 
abundant in the brain parenchyma. Small vessels within 
and adjacent to these foci showed endothelial cell prolif-
eration and perivascular cuffs of T-lymphocytes. Some 
areas showed conﬂ  uence of many recent and old necrotic 
lesions, leading to an extensive destruction in all cortical 
laminae, reactive ﬁ  brillary gliosis, and secondary demy-
elination in the underlying white matter. Organizing and 
active inﬂ  ammatory foci were present in the putamen, the 
globus pallidus, and claustrum. Examination of the spinal 
cord showed gross degeneration of corticospinal tracts and 
less pronounced degeneration in Goll columns. Perivascu-
lar cuffs of mononuclear cells were frequently found in the 
degenerating tracts and the adjacent areas (5,11).
Family 4
Family 4 comprised a woman with 3 sons and a daugh-
ter from consecutive marriages; VE developed in the eldest 
son (patient 4-1), his half-sibling (patient 4-2), and 1 of his 4 
children (patient 4-3). Patient 4-1 had a short febrile episode 
in 1952 at the age of 51 years; the following year, muscle 
stiffness and speech and gait abnormalities developed. Two 
years later, he had overt dementia, characteristic dysarthria, 
and spastic gait. He died 9 years after the onset of neurologic 
symptoms. The CSF specimen analyzed during the second 
year of illness showed pleocytosis (Table 2).
Patient 4-2 became visibly affected in 1965, shortly 
before the age of 47, 4 years after her half-brother’s death. 
The illness had an insidious onset, beginning with clum-
siness and decreasing muscle strength in the lower limbs. 
Further progression led to intellectual decline and slurred 
dysarthric speech. On examination, she was mute and 
moved slowly due to spasticity predominantly in the lower 
limbs. She died 6 years after the disease onset. Postmortem 
examination showed characteristic necrotic lesions with 
marked central lysis of tissue, reactive gliosis, and second-
ary demyelination in the underlying white matter. T-lym-
phocytes and rod-shaped microglia were present within the 
gray and white matter (5).
Sudden acute disease developed in patient 4-3 in 1971 
when she was 36 years of age, 10 years after her father’s 
death. At hospital admission, she was unresponsive, fe-
brile, and had neck stiffness and Kernig sign. She remained 
confused and lethargic for 4 weeks and thereafter showed 
signiﬁ  cant memory loss and signs of spasticity. Nine weeks 
later, her condition worsened; she remained unconscious 
on life support and died 11 months after disease onset.
Family 5
Family 5 consisted of parents and 5 siblings (3 sisters 
and 2 brothers); VE developed in 2 sisters. The younger of 
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Table 2. Laboratory investigations and postmortem findings in Viliuisk encephalomyelitis patients from 6 families* 
Family 1  Family 2  Family 3  Family 4  Family 5  Family 6  Laboratory and postmortem 
findings 1-1 1-2 1-3 2-1 2-2 3-1 3-2 4-1 4-2 4-3 5-1 5-2 6-1 6-2 6-3
Cerebrospinal fluid  












Predominant cell type  Lym  Lym  Lym  Lym  Lym  Lym 
Protein (mg/dL)  150 166 23 480 99 16 99 33 66 132 66 66 99
Bacterial culture  Neg Neg NA Neg Neg NA Neg NA NA NA NA Neg Neg
Postmortem
Inflamed meninges  + + + + + +
Micronecrotic lesions in 
the brain parenchyma 
++ + + + +
*NA, data not available; Lym, lymphocytes; Neg, negative; +, observed. Viliuisk Encephalomyelitis
the 2 affected sisters (patient 5-1) was the ﬁ  rst to exhibit 
a gradual cognitive decline, spastic gait, dysphonia, and 
slurred speech, but not overt dysarthria, at the age of 20 
years in 1957. The disease progressed very slowly; she be-
came globally demented and died 11 years after the onset.
Her older sister (patient 5-2) had a short ﬂ  ulike illness 
at the age of 34 years, while the index patient was still alive. 
This was followed by cognitive decline and slowness of 
movements. Examination during the second year of illness 
showed deepening dementia, moderate muscle weakness in 
the upper and lower limbs, increasing spasticity, and urine 
incontinence. The disease rapidly progressed, and the pa-
tient died 23 months after the onset of ﬂ  ulike symptoms. 
Postmortem study showed marked brain atrophy and wid-
ened ventricles and multiple fresh and organized necrotic 
foci surrounded by spongiform degeneration and reactive 
gliosis. Perivascular cuffs consisting of lymphocytes, plas-
ma, and polymorphonuclear cells were widespread in the 
affected portions of the cerebral cortex, subcortical ganglia, 
cerebellum, and inferior olives (11). No other members of 
the extended family were known to be affected.
Family 6
Family 6 included a man and his 2 consecutive wives; 
VE developed in all. The man (patient 6-1) was born in 
a disease-endemic region on the Viliui River near the vil-
lage where family 5 was identiﬁ  ed. At the age of 25 years, 
he moved to a small settlement in the suburbs of the capi-
tal city of Yakutsk (Figure). This migrant worker lived 
for many years with a local Yakut family and married a 
young member of the adopting family (patient 6-2). They 
had a healthy child. Around the time of symptom onset in 
1959, patient 6-1 moved to another village in this same area 
where his second wife, a local woman (patient 6-3) took 
care of him during his illness. At this time (late 1950s), no 
VE cases were known in this part of the country; neither the 
local people nor the practicing physicians in the region had 
ever seen or heard of VE.
The illness in patient 6-1 had an insidious onset when 
the patient was 46 years of age; he exhibited increasing 
clumsiness and loss of muscle strength in the lower limbs. 
A year later, his speech became dysarthric and his gait slow 
and spastic. He lost the ability to walk and speak around 
the 10th year of illness and died 13 years after the disease 
onset. The patient was repeatedly studied at the regional 
hospital.
In patient 6-2, an acute disease developed when she 
was 37 years of age, 17 years after her relationship with 
patient 6-1 ended. She sought treatment for fever, head-
ache, dizziness, chills, nausea and frequent vomiting, dip-
lopia, and abnormal behavior. Ten weeks later, she showed 
a substantial intellectual decline, slowness of movements, 
spasticity, limb ataxia, and slow abnormal gait with fre-
quent falls. Six months after the disease onset, she gained 
weight, became globally demented, and exhibited dysar-
thria, muscle weakness in the upper and lower limbs, and 
spastic gait. She died 27 months after the onset of symp-
toms. CSF studies during the illness showed inﬂ  ammatory 
response (Table 2).
Patient 6-3 became acutely ill at the age of 53 years, 2 
years after the death of patient 6-1. She experienced severe 
headache, chills, and nausea and vomiting. Six weeks after 
symptom onset, she had a second episode of febrile illness 
and was admitted to the hospital with high temperature; she 
was also disoriented and aggressive. Her condition wors-
ened and she died 26 weeks after disease onset. On post-
mortem examination, the meninges were inﬁ  ltrated; the 
cerebral cortex and other gray matter structures contained 
widespread micronecrotic foci surrounded by inﬂ  ammatory 
inﬁ  ltrates with a tendency for these lesions to be replaced 
with glioﬁ  brotic scars (5 [Case 1], 10).
Discussion
We studied 6 families that included 15 patients with a 
deﬁ  nitive diagnosis of VE, according to published clinical 
and neuropathologic criteria (3,4). The abrupt febrile disease 
onset in most of the studied patients, the developing me-
ningoencephalitis with CSF pleocytosis, and inﬂ  ammatory 
changes systematically found in the brain tissue strongly 
suggest that VE is an infectious disease. Furthermore, VE 
patients show evidence for intrathecal immunoglobulin G 
synthesis, which correlates with the clinical manifestations 
(12). The prolonged occurrence of increased cell count and 
elevated protein concentrations in the CSF, up to 5–6 years 
from the disease onset, and the development of chroni-
cally progressive dementia and movement abnormalities, 
suggest that the pathogen is an unconventional organism, 
which may explain the failure of its isolation and identiﬁ  -
cation (7).
Although the occurrence of VE exclusively in the Ya-
kut (Sakha) population may suggest a genetically deter-
mined susceptibility of the indigenous Viliui population, 
segregation analysis excluded Mendelian inheritance (7,8). 
A recent case-control study discovered allelic associations 
(p<0.05) between interferon-γ (IFN-γ) gene polymor-
phisms and VE susceptibility. Notably, allelic association 
was found only in older patients who survived the acute dis-
ease phase, which suggests that IFN-γ variants may be pre-
disposing to the development of chronic VE (T. Oleksyk, 
pers. comm.). The spread of VE to new geographic regions 
argues against the view that some Siberian subpopulations 
are more susceptible to VE than others.
Five families with >1 VE patient were identiﬁ  ed and 
studied in a high-incidence mid-Viliui region, but the most 
interesting data were obtained from studies of family 6 in 
a region located 400 km away from the peak VE-endem-
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ic region around Lake Mastakh, where VE has not been 
previously known. Transmission to unrelated persons in a 
new environment conﬁ  rms that prolonged intrahousehold 
contact is a signiﬁ  cant risk factor. VE transmission to un-
related persons was observed in several other families, but 
the clinical, pathologic, or epidemiologic documentation is 
insufﬁ  cient.
Our analysis shows that the most severe disease result-
ing in death after an acute illness occurred in secondary but 
not primary cases (families 1, 2, 4, and 6). This discordance 
between the primary and secondary cases within a family 
suggests that transmission of infection in the setting of 
close intrahousehold contact may result in shorter incuba-
tion times and faster progression of the illness. Variability 
of VE phenotypic manifestations has been reported (7), but 
it was instructive to observe extremely diverse outcomes in 
members of the same family.
In summary, VE is a unique meningoencephalitis oc-
curring in the Yakut (Sakha) population of Eastern Sibe-
ria. Although the pathogen has not been identiﬁ  ed, clinical 
and pathologic phenomena described here indicate that the 
only plausible explanation is underlying infection. Analy-
sis of case clustering in 6 families supports the view that 
VE can be transmitted in a setting of a prolonged intra-
household contact with a patient manifesting the disease. 
To our knowledge, this is the ﬁ  rst report of VE transmis-
sion to unrelated persons, occurring in a region in which 
VE has not been previously known. The spread from high-
incidence foci along the Viliui Valley to new geographic 
areas strongly indicates that VE is an emerging infectious 
disease.
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